Hepatocyte cytotoxicity evaluation with zinc oxide nanoparticles

A. Ra Kim, Farrukh Rafiq Ahmed, Gun Young Jung, Seung Woo Cho, Dong Ik Kim, Soong Ho Um

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Our innate immunity is composed of several integral leukocytes including neutrophil, NK cell, macrophage or so. They are usually known to produce reactive oxygen species (ROS), in order to induce cell damages by these oxidizing reagents, and finally disrupting mitochondrial membrane to release cytochrome c. It is quite interesting to cancer therapy that the overexpressed cytochrome c level by ROS can lead to cancer cell death. Activated neutrophils exert anti-tumor effects against several carcinomas such as human skin melanoma by the increased production of ROS. To mimic the natural killing system, several nanoparticulates which contain cytotoxic properties have been in demand. Representatively, zinc oxide (ZnO) nanoparticles have been reported to have anti-bacterial and anti-cancer activity against various cancer cell lines due to production of ROS. They are shown to have preferential anti-cancer activity possibly due to higher level of oxidants and ROS in cancer cells. Inspired by these studies, we carried out the cytotoxicity evaluation of ZnO nanoparticulates against hepatocellular carcinoma. Our investigations were conducted by (1) screening the best size of ZnO (among 5, 50, and 100 nm) and the optimized time for anti-cancer effect against HepG2 cell line, (2) determining the apoptosis in the cells, and (3) regulating the production of intracellular ROS by ZnO nanoparticles. The ZnO nanoparticles revealed the dose-dependent toxic effect on HepG2 cells, irrespective of the sizes.

Original languageEnglish
Pages (from-to)926-929
Number of pages4
JournalJournal of Biomedical Nanotechnology
Volume9
Issue number5
DOIs
Publication statusPublished - 2013 May 1

Fingerprint

Zinc Oxide
Cytotoxicity
Zinc oxide
Nanoparticles
Hepatocytes
Reactive Oxygen Species
Oxygen
Cells
Neoplasms
Cell death
Cytochromes c
Hep G2 Cells
Proteins
Neutrophils
Macrophages
Poisons
Oxidants
Cell Line
Tumors
Skin

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomedical Engineering
  • Materials Science(all)
  • Pharmaceutical Science

Cite this

Kim, A. Ra ; Ahmed, Farrukh Rafiq ; Jung, Gun Young ; Cho, Seung Woo ; Kim, Dong Ik ; Um, Soong Ho. / Hepatocyte cytotoxicity evaluation with zinc oxide nanoparticles. In: Journal of Biomedical Nanotechnology. 2013 ; Vol. 9, No. 5. pp. 926-929.
@article{1e670a88e70c47deb53cd3492b995853,
title = "Hepatocyte cytotoxicity evaluation with zinc oxide nanoparticles",
abstract = "Our innate immunity is composed of several integral leukocytes including neutrophil, NK cell, macrophage or so. They are usually known to produce reactive oxygen species (ROS), in order to induce cell damages by these oxidizing reagents, and finally disrupting mitochondrial membrane to release cytochrome c. It is quite interesting to cancer therapy that the overexpressed cytochrome c level by ROS can lead to cancer cell death. Activated neutrophils exert anti-tumor effects against several carcinomas such as human skin melanoma by the increased production of ROS. To mimic the natural killing system, several nanoparticulates which contain cytotoxic properties have been in demand. Representatively, zinc oxide (ZnO) nanoparticles have been reported to have anti-bacterial and anti-cancer activity against various cancer cell lines due to production of ROS. They are shown to have preferential anti-cancer activity possibly due to higher level of oxidants and ROS in cancer cells. Inspired by these studies, we carried out the cytotoxicity evaluation of ZnO nanoparticulates against hepatocellular carcinoma. Our investigations were conducted by (1) screening the best size of ZnO (among 5, 50, and 100 nm) and the optimized time for anti-cancer effect against HepG2 cell line, (2) determining the apoptosis in the cells, and (3) regulating the production of intracellular ROS by ZnO nanoparticles. The ZnO nanoparticles revealed the dose-dependent toxic effect on HepG2 cells, irrespective of the sizes.",
author = "Kim, {A. Ra} and Ahmed, {Farrukh Rafiq} and Jung, {Gun Young} and Cho, {Seung Woo} and Kim, {Dong Ik} and Um, {Soong Ho}",
year = "2013",
month = "5",
day = "1",
doi = "10.1166/jbn.2013.1495",
language = "English",
volume = "9",
pages = "926--929",
journal = "Journal of Biomedical Nanotechnology",
issn = "1550-7033",
publisher = "American Scientific Publishers",
number = "5",

}

Hepatocyte cytotoxicity evaluation with zinc oxide nanoparticles. / Kim, A. Ra; Ahmed, Farrukh Rafiq; Jung, Gun Young; Cho, Seung Woo; Kim, Dong Ik; Um, Soong Ho.

In: Journal of Biomedical Nanotechnology, Vol. 9, No. 5, 01.05.2013, p. 926-929.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Hepatocyte cytotoxicity evaluation with zinc oxide nanoparticles

AU - Kim, A. Ra

AU - Ahmed, Farrukh Rafiq

AU - Jung, Gun Young

AU - Cho, Seung Woo

AU - Kim, Dong Ik

AU - Um, Soong Ho

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Our innate immunity is composed of several integral leukocytes including neutrophil, NK cell, macrophage or so. They are usually known to produce reactive oxygen species (ROS), in order to induce cell damages by these oxidizing reagents, and finally disrupting mitochondrial membrane to release cytochrome c. It is quite interesting to cancer therapy that the overexpressed cytochrome c level by ROS can lead to cancer cell death. Activated neutrophils exert anti-tumor effects against several carcinomas such as human skin melanoma by the increased production of ROS. To mimic the natural killing system, several nanoparticulates which contain cytotoxic properties have been in demand. Representatively, zinc oxide (ZnO) nanoparticles have been reported to have anti-bacterial and anti-cancer activity against various cancer cell lines due to production of ROS. They are shown to have preferential anti-cancer activity possibly due to higher level of oxidants and ROS in cancer cells. Inspired by these studies, we carried out the cytotoxicity evaluation of ZnO nanoparticulates against hepatocellular carcinoma. Our investigations were conducted by (1) screening the best size of ZnO (among 5, 50, and 100 nm) and the optimized time for anti-cancer effect against HepG2 cell line, (2) determining the apoptosis in the cells, and (3) regulating the production of intracellular ROS by ZnO nanoparticles. The ZnO nanoparticles revealed the dose-dependent toxic effect on HepG2 cells, irrespective of the sizes.

AB - Our innate immunity is composed of several integral leukocytes including neutrophil, NK cell, macrophage or so. They are usually known to produce reactive oxygen species (ROS), in order to induce cell damages by these oxidizing reagents, and finally disrupting mitochondrial membrane to release cytochrome c. It is quite interesting to cancer therapy that the overexpressed cytochrome c level by ROS can lead to cancer cell death. Activated neutrophils exert anti-tumor effects against several carcinomas such as human skin melanoma by the increased production of ROS. To mimic the natural killing system, several nanoparticulates which contain cytotoxic properties have been in demand. Representatively, zinc oxide (ZnO) nanoparticles have been reported to have anti-bacterial and anti-cancer activity against various cancer cell lines due to production of ROS. They are shown to have preferential anti-cancer activity possibly due to higher level of oxidants and ROS in cancer cells. Inspired by these studies, we carried out the cytotoxicity evaluation of ZnO nanoparticulates against hepatocellular carcinoma. Our investigations were conducted by (1) screening the best size of ZnO (among 5, 50, and 100 nm) and the optimized time for anti-cancer effect against HepG2 cell line, (2) determining the apoptosis in the cells, and (3) regulating the production of intracellular ROS by ZnO nanoparticles. The ZnO nanoparticles revealed the dose-dependent toxic effect on HepG2 cells, irrespective of the sizes.

UR - http://www.scopus.com/inward/record.url?scp=84877771523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877771523&partnerID=8YFLogxK

U2 - 10.1166/jbn.2013.1495

DO - 10.1166/jbn.2013.1495

M3 - Article

C2 - 23802425

AN - SCOPUS:84877771523

VL - 9

SP - 926

EP - 929

JO - Journal of Biomedical Nanotechnology

JF - Journal of Biomedical Nanotechnology

SN - 1550-7033

IS - 5

ER -